Wanbury Limited (WANBURY.NS)
INR 288.74
(-5.0%)
INR 288.74
(-5.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.16 Billion INR | 70.63% |
| 2022 | 682.68 Million INR | -36.59% |
| 2021 | 1.07 Billion INR | -47.18% |
| 2020 | 2.03 Billion INR | -2.16% |
| 2019 | 2.08 Billion INR | -27.59% |
| 2018 | 2.87 Billion INR | 3.17% |
| 2017 | 2.78 Billion INR | -27.98% |
| 2016 | 3.87 Billion INR | 20.42% |
| 2015 | 3.21 Billion INR | -7.7% |
| 2014 | 3.48 Billion INR | 0.0% |
| 2012 | 3.75 Billion INR | 9.32% |
| 2011 | 3.43 Billion INR | -32.27% |
| 2010 | 5.06 Billion INR | 8.07% |
| 2009 | 4.68 Billion INR | -0.82% |
| 2008 | 4.72 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.16 Billion INR | 0.0% |
| 2023 FY | 1.16 Billion INR | 70.63% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.13 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 682.68 Million INR | -36.59% |
| 2022 Q4 | 682.68 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 663.36 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 1.63 Billion INR | 0.0% |
| 2021 FY | 1.07 Billion INR | -47.18% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 1.07 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 2.03 Billion INR | 0.0% |
| 2020 FY | 2.03 Billion INR | -2.16% |
| 2020 Q2 | 1.09 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 2.08 Billion INR | -27.59% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 2.08 Billion INR | 0.0% |
| 2019 Q2 | 1.47 Billion INR | 0.0% |
| 2018 FY | 2.87 Billion INR | 3.17% |
| 2018 Q4 | 2.87 Billion INR | 0.0% |
| 2017 FY | 2.78 Billion INR | -27.98% |
| 2016 FY | 3.87 Billion INR | 20.42% |
| 2015 FY | 3.21 Billion INR | -7.7% |
| 2014 FY | 3.48 Billion INR | 0.0% |
| 2012 FY | 3.75 Billion INR | 9.32% |
| 2011 FY | 3.43 Billion INR | -32.27% |
| 2010 FY | 5.06 Billion INR | 8.07% |
| 2009 FY | 4.68 Billion INR | -0.82% |
| 2008 Q4 | 4.72 Billion INR | 0.0% |
| 2008 FY | 4.72 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | 18.572% |
| Ind-Swift Limited | 10.13 Billion INR | 88.512% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 65.001% |
| Sakar Healthcare Limited | 793.51 Million INR | -46.796% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 98.248% |
| Innova Captab Limited | 2.45 Billion INR | 52.475% |
| Divi's Laboratories Limited | 30 Million INR | -3782.82% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -2433.265% |
| Morepen Laboratories Limited | 289.99 Million INR | -301.682% |
| Mankind Pharma Limited | 2.07 Billion INR | 43.774% |
| Sequent Scientific Limited | 4.87 Billion INR | 76.115% |
| Laurus Labs Limited | 25.77 Billion INR | 95.481% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 81.671% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -579.29% |
| Alembic Limited | 91.5 Million INR | -1173.056% |
| Hikal Limited | 8.17 Billion INR | 85.753% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 77.301% |
| Neuland Laboratories Limited | 953.89 Million INR | -22.115% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 69.156% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 90.537% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -255.57% |
| Themis Medicare Limited | 957.92 Million INR | -21.601% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 85.515% |
| Lupin Limited | 29.21 Billion INR | 96.013% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -6639.837% |
| Wockhardt Limited | 23.56 Billion INR | 95.056% |
| Vaishali Pharma Limited | 134.91 Million INR | -763.373% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 59.164% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -1202.814% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 96.821% |
| FDC Limited | 205.18 Million INR | -467.705% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 94.182% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -268.081% |
| Eris Lifesciences Limited | 27.81 Billion INR | 95.812% |
| Venus Remedies Limited | 413.3 Million INR | -181.84% |
| ZIM Laboratories Limited | 1.08 Billion INR | -7.039% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -16.671% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -5812.924% |
| Shilpa Medicare Limited | 9.37 Billion INR | 87.573% |
| Albert David Limited | 33.24 Million INR | -3404.139% |
| Ajanta Pharma Limited | 352.8 Million INR | -230.172% |
| Hester Biosciences Limited | 2.44 Billion INR | 52.334% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -79.217% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 88.484% |
| Gufic Biosciences Limited | 3.32 Billion INR | 65.011% |
| Windlas Biotech Limited | 36.41 Million INR | -3099.247% |
| Procter & Gamble Health Limited | 95.6 Million INR | -1118.458% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -271.534% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -18.267% |
| Granules India Limited | 13.15 Billion INR | 91.142% |
| Aarti Drugs Limited | 5.64 Billion INR | 79.357% |
| Bal Pharma Limited | 1.39 Billion INR | 16.587% |
| Alkem Laboratories Limited | 14.18 Billion INR | 91.788% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 96.442% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -10819.066% |
| Medicamen Biotech Limited | 308.17 Million INR | -277.986% |
| Unichem Laboratories Limited | 2.47 Billion INR | 52.938% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -377.605% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -26440.123% |
| Valiant Laboratories Limited | 767.08 Million INR | -51.854% |
| Orchid Pharma Limited | 1.35 Billion INR | 13.83% |
| Medico Remedies Limited | 80.5 Million INR | -1346.942% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -600.803% |
| Ipca Laboratories Limited | 14.38 Billion INR | 91.902% |
| Brooks Laboratories Limited | 56.41 Million INR | -1964.634% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -60.698% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.783% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 97.104% |
| NATCO Pharma Limited | 3.71 Billion INR | 68.619% |
| Suven Life Sciences Limited | 7.09 Million INR | -16313.217% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 39.779% |
| Strides Pharma Science Limited | 25.16 Billion INR | 95.372% |
| Indoco Remedies Limited | 6.71 Billion INR | 82.665% |
| Alpa Laboratories Limited | 52.46 Million INR | -2120.234% |
| Lasa Supergenerics Limited | 220.76 Million INR | -427.648% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -90.49% |